| Website | solsticeneuro.com |
| Category | BioTech |
| Phone | 650-243-4400 |
| contact@solsticen... | |
| Employees |
| TOTAL | $93M |
| FUNDING TOTAL | $93M |
| Venture Round, 7/05 Morgan Stanley Venture Partners Thomas, McNerney & Partners Oxford Bioscience Partners Investor AB | $8M |
| Series B, 11/06 Highland Capital Partners Thomas, McNerney & Partners Investor Growth Capital Morgan Stanley Venture Partners Oxford Bioscience Partners | $85M |
Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice’s first product named Myobloc® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.
